Iptacopan 200mg capsules
NHS hospitals in England used £45,525,925 of indicative cost of Iptacopan 200mg capsules in the 12 months to April 2026, about 0.2% of all hospital medicines spend. That is up 94.1% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Iptacopan 200mg capsules: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to April 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Iptacopan 200mg capsules most
By indicative cost over the 12 months to April 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Leeds Teaching Hpls Nhs Trust | £22,681,840 |
| King's College Hpl Nhs Foundation Trust | £19,797,160 |
| Imperial College Healthcare Nhs Trust | £556,500 |
| Salford Royal Nhs Foundation Trust | £496,875 |
| Barts Health Nhs Trust | £397,500 |
| University College London Foundation Tr | £387,275 |
| North Bristol Nhs Trust | £318,000 |
| Norfolk & Norwich University Hpl Nhs Trt | £318,000 |
| University Hpls Of Leicester Nhs Trust | £281,275 |
| The Newcastle Upon Tyne Hpl Nhs Found Tr | £159,000 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.